<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005201A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005201</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14016685</doc-number><date>20130903</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>471</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>487</main-group><subgroup>04</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>471</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>487</main-group><subgroup>04</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514249</main-classification><further-classification>544350</further-classification><further-classification>546119</further-classification><further-classification>514303</further-classification></classification-national><invention-title id="d0e43">Tricyclic imidazole compounds as PDE10 inhibitors</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>13299368</doc-number><date>20111118</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8552045</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14016685</doc-number></document-id></child-doc></relation></division><us-provisional-application><document-id><country>US</country><doc-number>61415356</doc-number><date>20101119</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>H. Lundbeck A/S</orgname><address><city>Valby-Copenhagen</city><country>DK</country></address></addressbook><residence><country>DK</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Kehler</last-name><first-name>Jan</first-name><address><city>Lyngby</city><country>DK</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Nielsen</last-name><first-name>Jacob</first-name><address><city>Kobenhavn V</city><country>DK</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Marigo</last-name><first-name>Mauro</first-name><address><city>Skovlunde</city><country>DK</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Kilburn</last-name><first-name>John Paul</first-name><address><city>Haslev</city><country>DK</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Langg&#xe5;rd</last-name><first-name>Morten</first-name><address><city>Glostrup</city><country>DK</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>H. Lundbeck A/S</orgname><role>03</role><address><city>Valby-Copenhagen</city><country>DK</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.</p></abstract></us-patent-application>